Provided by Tiger Trade Technology Pte. Ltd.

Teva Pharmaceutical

38.10
+1.173.17%
Post-market: 38.00-0.1000-0.26%19:59 EDT
Volume:5.28M
Turnover:199.59M
Market Cap:44.39B
PE:63.50
High:38.11
Open:37.13
Low:37.09
Close:36.93
52wk High:38.11
52wk Low:17.82
Shares:1.17B
Float Shares:1.09B
Volume Ratio:1.00
T/O Rate:0.49%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.6000
EPS(LYR):1.21
ROE:9.69%
ROA:5.13%
PB:5.73
PE(LYR):31.49

Loading ...

Teva Pharmaceutical Industries Ltd expected to post earnings of 46 cents a share - Earnings Preview

Reuters
·
Apr 27

Earning Preview: Teva Pharmaceutical this quarter’s revenue is expected to decrease by 4.49%, and institutional views are bullish

Earnings Agent
·
Apr 23

Teva put volume heavy and directionally bearish

TIPRANKS
·
Apr 21

Assessing Teva Pharmaceutical Industries (NYSE:TEVA) Valuation After The Home Ground Schizophrenia Platform Launch

Simply Wall St.
·
Apr 19

US appeals court revives Teva lawsuit against Eli Lilly over migraine drug

Reuters
·
Apr 16

Does Biosimilar Wins in Osteoporosis and Allergy Care Change The Bull Case For Teva (TEVA)?

Simply Wall St.
·
Apr 13

Teva Pharmaceuticals Is Maintained at Buy by B of A Securities

Dow Jones
·
Apr 10

Biopharma Stocks Largely Exempt From Pharma Tariffs, BofA Says

MT Newswires Live
·
Apr 09

BofA Adjusts Price Target on Teva Pharmaceutical Industries to $42 From $38, Maintains Buy Rating

MT Newswires Live
·
Apr 09

How Investors Are Reacting To Teva (TEVA) Advancing Its Biosimilar Pipeline With New FDA and EMA Milestones

Simply Wall St.
·
Apr 04

Teva’s New Biosimilars Test Growth Plan And Earnings Reshaping Potential

Simply Wall St.
·
Mar 31

Teva call volume above normal and directionally bullish

TIPRANKS
·
Mar 31

Barclays Sticks to Its Buy Rating for Teva Pharmaceutical (TEVA)

TIPRANKS
·
Mar 30

How Investors May Respond To Teva (TEVA) Advancing TEV ‘325 In Biologics For Inflammatory Diseases

Simply Wall St.
·
Mar 26

Scotiabank Remains a Buy on Teva Pharmaceutical (TEVA)

TIPRANKS
·
Mar 25

Enphase, AST SpaceMobile, AppLovin, ConocoPhillips, Teva Shock

TIPRANKS
·
Mar 21

Barclays Reaffirms Their Buy Rating on Teva Pharmaceutical (TEVA)

TIPRANKS
·
Mar 20

Top Teva Executive Makes Major Stock Move That Investors Can’t Ignore

TIPRANKS
·
Mar 20

A Look At Teva Pharmaceutical Industries (NYSE:TEVA) Valuation After Branded Drugs Pass $1b Quarterly Revenue

Simply Wall St.
·
Mar 17

J.P. Morgan Sticks to Their Buy Rating for Teva Pharmaceutical (TEVA)

TIPRANKS
·
Mar 05